Dr. Theodore August Pasquali, MD

Dr. Pasquali practices at SoCal Eye Surgery Center in Long Beach, California.

Dr. Pasquali's NPI, 1164682738, was assigned on June 16, 2008. Dr. Pasquali graduated from David Geffen School of Medicine at UCLA in 2008. Dr. Pasquali holds California license A 126375.

Dr. Pasquali's primary practice is SoCal Eye Surgery Center, at 3300 East South St, Long Beach, CA 90805. The practice phone is (562) 531-2020.

Dr. Pasquali's primary practice is SoCal Eye Surgery Center in Long Beach, California. Dmand AI also links Dr. Pasquali to 1 medical group, named with a free account. Dr. Pasquali's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasquali practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Pasquali's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Pasquali is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pasquali's licenses on file in 3 states: California, Kansas and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Pasquali treats.

CMS data shows 1,548 Medicare services from Dr. Pasquali across 13 procedure codes in 2024, for 562 Medicare patients. Medicare paid $133,265 for them.

CMS counts 562 Medicare patients who saw Dr. Pasquali in 2024. The largest group is 75 to 84, with 239 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pasquali's median patient age at 73, with 59% women.

In 2024, Dr. Pasquali wrote 2,210 Medicare Part D claims for 660 patients. 58% of them were for generic drugs. CMS names the drug for 2,113 of them, across 20 drugs with 11 or more claims each, at $173,836 in total drug cost. In 2023, CMS named 2,323 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Pasquali for performance year 2024, reported as part of a group. Dr. Pasquali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 184 procedures of cataract surgery by Dr. Pasquali, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Pasquali. The most frequent topics are Keratomileusis, Laser In Situ, Conjunctival Diseases and Lasers, Excimer. Dr. Pasquali's most frequent co-authors are Jason Philip Brinton, MD, Daniel S. Durrie, MD and Ronald R. Krueger, MD.

CMS Open Payments shows 69 general payments to Dr. Pasquali from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Glaukos Corporation paid the most, $1,520.

Dmand AI lists 1 award for Dr. Pasquali, most recently Phi Beta Kappa in 2001.

Dr. Pasquali graduated from David Geffen School of Medicine at UCLA in 2008.

Dr. Pasquali is in network with 20 carriers, including Aetna, HCSC and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.